DRREDDY:NSE
Dr Reddy's Laboratories Ltd
1 199,80 ₹
arrow_upward
+1,68%(+19,80) 1D
9 tet, 3:30:00 m.d., GMT+5:30 · INR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për DRREDDY...
Hap
1 180,00 ₹
I lartë
1 200,80 ₹
I ulët
1 172,00 ₹
Kapitalizimi i tregut
997,09Â mld
Vëllimi mesatar
1,81Â mln
Vëllimi
1,51Â mln
Dividendi
0,67%
Dividendi tremujor
2,00 ₹
Data e ndërprerjes së dividendit
10 korr 2026
Raporti çmim/fitim
31,03
Maksimumi 52-javor
1 414,90 ₹
Minimumi 52-javor
1 101,00 ₹
Fitimet për aksion
38,67 ₹
Aksionet në qarkullim
166,06Â mln
Numri i punonjësve
28 mijë
Hap
1 180,00 ₹
I lartë
1 200,80 ₹
I ulët
1 172,00 ₹
Kapitalizimi i tregut
997,09Â mld
Vëllimi mesatar
1,81Â mln
Vëllimi
1,51Â mln
Dividendi
0,67%
Dividendi tremujor
2,00 ₹
Data e ndërprerjes së dividendit
10 korr 2026
Raporti çmim/fitim
31,03
Maksimumi 52-javor
1 414,90 ₹
Minimumi 52-javor
1 101,00 ₹
Fitimet për aksion
38,67 ₹
Aksionet në qarkullim
166,06Â mln
Numri i punonjësve
28 mijë
Aksionet e lidhura
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AskTraders.com
·
14 minuta më parë
S&P 500: Why UBS Says Investors Should ‘Stay Invested Near Record Highs’
Yahoo Finance
·
1 orë më parë
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Benzinga
·
1 orë më parë
Dow Jones, S&P 500, Nasdaq 100 Outlook: Top Stock Market News This Week
24/7 Wall St.
·
5 orë më parë
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profili
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Rreth Dr Reddy's Laboratories Ltd
Drejtori ekzekutivErez Israeli
Punonjësit27,5 mijë
Themeluar më1984
SeliaHiderabad, Andra Pradesh, Indi
Sektori-
Uebsajtidrreddys.com